Angiomyolipoma of the Hard Palate.

The Journal of Craniofacial Surgery
Hüseyin Akçay, Berat Metin Adak

Abstract

Angiomyolipoma (AML) is a tumor which commonly affects the kidney. Few authors have been reported AML in the oral cavity. In this clinical report, an AML of the hard palate will be presented in a 48-year-old patient. The AML contains mature adipose tissue, thick-walled blood vessels, and irregular bundle of smooth muscle. The AML is sometimes associated with tuberous sclerosis. Although the renal AMLs are often invasive, they involve regional nodes and may recur, extrarenal AMLs are commonly well demarcated, show no recurrence and may simply be removed. The AML usually behaves in a benign fashion.

References

Apr 1, 1995·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·K YamamotoT Osaki
Aug 24, 1999·Archives of Pathology & Laboratory Medicine·K Watanabe, T Suzuki
Apr 5, 2001·Oral Oncology·A PiattelliE Fiera
Jul 17, 2007·The British Journal of Oral & Maxillofacial Surgery·H KoizumiM Kogo
May 21, 2010·The Journal of Craniofacial Surgery·Ilknur HaberalEthem Erdal Samim
Jun 17, 2015·Türk Pediatri Arşivi·İlknur ErolÖzlem Alkan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.